Literature DB >> 26887781

Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society.

Koji Umeshita1, Yukihiro Inomata2, Hiroyuki Furukawa3, Mureo Kasahara4, Seiji Kawasaki5, Eiji Kobayashi6, Norihiro Kokudo7, Shotaro Sakisaka8, Mitsuo Shimada9, Eiji Tanaka10, Shinji Uemoto11.   

Abstract

As of December 31, 2013, a total of 7474 liver transplants have been carried out at 66 institutions in Japan. This total included 7255 living-donor transplants and 219 deceased-donor transplants (216 from heart-beating donors and 3 from non-heart-beating donors). The annual total of liver transplants in 2013 decreased to 408, from 422 in 2012. The number of liver transplants from living donors decreased to 369, from 381, whereas the number of liver transplants from heart-beating deceased donors did not change significantly. The most frequent indication was cholestatic disease, followed by neoplastic disease. In terms of graft liver in living-donor cases, right-lobe graft was the most popular (36%). Patient survival following transplantations from heart-beating donors (1 year, 85.9%; 3 years, 82.6%; 5 years, 81.3%; 10 years, 73.8%) was similar to those from living donors (1 year, 83.8%; 3 years, 79.6%; 5 years, 77.1%; 10 years, 71.9%; 15 years, 67.8%; 20 years, 66.1%). Graft survival was very much the same as patient survival. As for ABO-incompatible transplantation, transplant period affected the outcome significantly, probably due to local infusion therapy and rituximab prophylaxis, which were introduced in many transplant centers after 2000 and 2004, respectively.
© 2016 The Japan Society of Hepatology.

Entities:  

Keywords:  Japan; donor; liver transplantation; national registry; recipient; survival

Year:  2016        PMID: 26887781     DOI: 10.1111/hepr.12676

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  13 in total

1.  Living donor liver transplantation for patients with hepatocellular carcinoma-20 years after introduction of the Milan criteria.

Authors:  Yasuhiko Sugawara
Journal:  Hepatobiliary Surg Nutr       Date:  2016-12       Impact factor: 7.293

Review 2.  Living donor liver transplantation for hepatocellular cancer: an (almost) exclusive Eastern procedure?

Authors:  Rafael S Pinheiro; Daniel R Waisberg; Lucas S Nacif; Vinicius Rocha-Santos; Rubens M Arantes; Liliana Ducatti; Rodrigo B Martino; Quirino Lai; Wellington Andraus; Luiz A C D'Albuquerque
Journal:  Transl Gastroenterol Hepatol       Date:  2017-08-29

3.  Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital.

Authors:  Junichi Togashi; Nobuhisa Akamastu; Norihiro Kokudo
Journal:  Hepatobiliary Surg Nutr       Date:  2016-10       Impact factor: 7.293

4.  First successful perinatal management of pregnancy after ABO-incompatible liver transplantation.

Authors:  Hisanobu Higashi; Hideaki Obara; Kei Miyakoshi; Masahiro Shinoda; Minoru Kitago; Naoki Shimojima; Yuta Abe; Taizo Hibi; Hiroshi Yagi; Kentaro Matsubara; Yohei Yamada; Osamu Itano; Ken Hoshino; Tatsuo Kuroda; Yuko Kitagawa
Journal:  World J Gastroenterol       Date:  2017-01-21       Impact factor: 5.742

5.  Rescue case of low birth weight infant with acute hepatic failure.

Authors:  Noriki Okada; Yukihiro Sanada; Taizen Urahashi; Yoshiyuki Ihara; Naoya Yamada; Yuta Hirata; Takumi Katano; Kentaro Ushijima; Shinya Otomo; Shujiro Fujita; Koichi Mizuta
Journal:  World J Gastroenterol       Date:  2017-10-28       Impact factor: 5.742

6.  Biliary-duodenal anastomosis using magnetic compression following massive resection of small intestine due to strangulated ileus after living donor liver transplantation: a case report.

Authors:  Ryusuke Saito; Hiroyuki Tahara; Seiichi Shimizu; Masahiro Ohira; Kentaro Ide; Kohei Ishiyama; Tsuyoshi Kobayashi; Hideki Ohdan
Journal:  Surg Case Rep       Date:  2017-05-25

7.  Long-term Outcomes of ABO-incompatible Pediatric Living Donor Liver Transplantation.

Authors:  Masaki Honda; Yasuhiko Sugawara; Masashi Kadohisa; Keita Shimata; Masataka Sakisaka; Daiki Yoshii; Keiichi Uto; Shintaro Hayashida; Yuki Ohya; Hidekazu Yamamoto; Hirotoshi Yamamoto; Yukihiro Inomata; Taizo Hibi
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

8.  "Real-time" risk models of postoperative morbidity and mortality for liver transplants.

Authors:  Shigeru Marubashi; Naoaki Ichihara; Yoshihiro Kakeji; Hiroaki Miyata; Akinobu Taketomi; Hiroto Egawa; Yasutsugu Takada; Koji Umeshita; Yasuyuki Seto; Mitsukazu Gotoh
Journal:  Ann Gastroenterol Surg       Date:  2018-11-02

9.  Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study.

Authors:  Daisuke Ueda; Atsushi Yoshizawa; Masakatsu Kaneshiro; Yoshihiro Hirata; Shintaro Yagi; Koichiro Hata; Hideaki Okajima; Hiroto Egawa; Shinji Uemoto
Journal:  Transplant Direct       Date:  2018-12-27

10.  Outcomes of Living Donor Liver Transplantation Alone for Patients on Maintenance Renal Replacement Therapy in Japan: Results of a Nationwide Survey.

Authors:  Susumu Eguchi; Hiroyuki Furukawa; Shinji Uemoto; Koji Umeshita; Hajime Imamura; Akihiko Soyama; Tsuyoshi Shimamura; Shuji Isaji; Yasuhiro Ogura; Hiroto Egawa; Shigeyuki Kawachi; Mureo Kasahara; Hiroaki Nagano; Yonson Ku; Hideki Ohdan; Yoshihiko Maehara; Shuntaro Sato; Yukihiro Inomata
Journal:  Transplant Direct       Date:  2016-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.